Global Long-Acting Injectable (LAI) Antipsychotic Market 2023 by Company, Regions, Type and Application, Forecast to 2029
According to our (Global Info Research) latest study, the global Long-Acting Injectable (LAI) Antipsychotic market size was valued at USD million in 2022 and is forecast to a readjusted size of USD million by 2029 with a CAGR of % during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication.
This report is a detailed and comprehensive analysis for global Long-Acting Injectable (LAI) Antipsychotic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Long-Acting Injectable (LAI) Antipsychotic market size and forecasts, in consumption value ($ Million), 2018-2029
Global Long-Acting Injectable (LAI) Antipsychotic market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Long-Acting Injectable (LAI) Antipsychotic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Long-Acting Injectable (LAI) Antipsychotic market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Long-Acting Injectable (LAI) Antipsychotic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Long-Acting Injectable (LAI) Antipsychotic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alkermes, Eli Lilly and Company, Janssen Global Services, LLC, Abilify Maintena and Haldol, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Long-Acting Injectable (LAI) Antipsychotic market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Chapter 1, to describe Long-Acting Injectable (LAI) Antipsychotic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Long-Acting Injectable (LAI) Antipsychotic, with revenue, gross margin and global market share of Long-Acting Injectable (LAI) Antipsychotic from 2018 to 2023.
Chapter 3, the Long-Acting Injectable (LAI) Antipsychotic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Long-Acting Injectable (LAI) Antipsychotic market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Long-Acting Injectable (LAI) Antipsychotic.
Chapter 13, to describe Long-Acting Injectable (LAI) Antipsychotic research findings and conclusion.
Long-acting injectable (LAI) antipsychotics are a pharmacologic strategy for treating patients with schizophrenia who relapse due to nonadherence to antipsychotic medication.
This report is a detailed and comprehensive analysis for global Long-Acting Injectable (LAI) Antipsychotic market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Long-Acting Injectable (LAI) Antipsychotic market size and forecasts, in consumption value ($ Million), 2018-2029
Global Long-Acting Injectable (LAI) Antipsychotic market size and forecasts by region and country, in consumption value ($ Million), 2018-2029
Global Long-Acting Injectable (LAI) Antipsychotic market size and forecasts, by Type and by Application, in consumption value ($ Million), 2018-2029
Global Long-Acting Injectable (LAI) Antipsychotic market shares of main players, in revenue ($ Million), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Long-Acting Injectable (LAI) Antipsychotic
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Long-Acting Injectable (LAI) Antipsychotic market based on the following parameters - company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Alkermes, Eli Lilly and Company, Janssen Global Services, LLC, Abilify Maintena and Haldol, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market segmentation
Long-Acting Injectable (LAI) Antipsychotic market is split by Type and by Application. For the period 2018-2029, the growth among segments provide accurate calculations and forecasts for consumption value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Aripiprazole
- Fluphenazine
- Haloperidol
- Others
- Hospital
- Retail Pharmacy
- Others
- Alkermes
- Eli Lilly and Company
- Janssen Global Services, LLC
- Abilify Maintena
- Haldol
- Otsuka Pharmaceutical
- Aristada
- Prolixin
- North America (United States, Canada, and Mexico)
- Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
- Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)
- South America (Brazil, Argentina and Rest of South America)
- Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
Chapter 1, to describe Long-Acting Injectable (LAI) Antipsychotic product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Long-Acting Injectable (LAI) Antipsychotic, with revenue, gross margin and global market share of Long-Acting Injectable (LAI) Antipsychotic from 2018 to 2023.
Chapter 3, the Long-Acting Injectable (LAI) Antipsychotic competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and application, with consumption value and growth rate by Type, application, from 2018 to 2029.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2018 to 2023.and Long-Acting Injectable (LAI) Antipsychotic market forecast, by regions, type and application, with consumption value, from 2024 to 2029.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War
Chapter 12, the key raw materials and key suppliers, and industry chain of Long-Acting Injectable (LAI) Antipsychotic.
Chapter 13, to describe Long-Acting Injectable (LAI) Antipsychotic research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope of Long-Acting Injectable (LAI) Antipsychotic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Long-Acting Injectable (LAI) Antipsychotic by Type
1.3.1 Overview: Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type in 2022
1.3.3 Aripiprazole
1.3.4 Fluphenazine
1.3.5 Haloperidol
1.3.6 Others
1.4 Global Long-Acting Injectable (LAI) Antipsychotic Market by Application
1.4.1 Overview: Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Others
1.5 Global Long-Acting Injectable (LAI) Antipsychotic Market Size & Forecast
1.6 Global Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast by Region
1.6.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region, (2018-2029)
1.6.3 North America Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
1.6.4 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
1.6.6 South America Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Alkermes
2.1.1 Alkermes Details
2.1.2 Alkermes Major Business
2.1.3 Alkermes Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.1.4 Alkermes Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alkermes Recent Developments and Future Plans
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.2.4 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eli Lilly and Company Recent Developments and Future Plans
2.3 Janssen Global Services, LLC
2.3.1 Janssen Global Services, LLC Details
2.3.2 Janssen Global Services, LLC Major Business
2.3.3 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.3.4 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Janssen Global Services, LLC Recent Developments and Future Plans
2.4 Abilify Maintena
2.4.1 Abilify Maintena Details
2.4.2 Abilify Maintena Major Business
2.4.3 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.4.4 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Abilify Maintena Recent Developments and Future Plans
2.5 Haldol
2.5.1 Haldol Details
2.5.2 Haldol Major Business
2.5.3 Haldol Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.5.4 Haldol Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Haldol Recent Developments and Future Plans
2.6 Otsuka Pharmaceutical
2.6.1 Otsuka Pharmaceutical Details
2.6.2 Otsuka Pharmaceutical Major Business
2.6.3 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.6.4 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Otsuka Pharmaceutical Recent Developments and Future Plans
2.7 Aristada
2.7.1 Aristada Details
2.7.2 Aristada Major Business
2.7.3 Aristada Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.7.4 Aristada Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Aristada Recent Developments and Future Plans
2.8 Prolixin
2.8.1 Prolixin Details
2.8.2 Prolixin Major Business
2.8.3 Prolixin Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.8.4 Prolixin Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Prolixin Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Long-Acting Injectable (LAI) Antipsychotic Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Long-Acting Injectable (LAI) Antipsychotic by Company Revenue
3.2.2 Top 3 Long-Acting Injectable (LAI) Antipsychotic Players Market Share in 2022
3.2.3 Top 6 Long-Acting Injectable (LAI) Antipsychotic Players Market Share in 2022
3.3 Long-Acting Injectable (LAI) Antipsychotic Market: Overall Company Footprint Analysis
3.3.1 Long-Acting Injectable (LAI) Antipsychotic Market: Region Footprint
3.3.2 Long-Acting Injectable (LAI) Antipsychotic Market: Company Product Type Footprint
3.3.3 Long-Acting Injectable (LAI) Antipsychotic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value and Market Share by Type (2018-2023)
4.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2023)
5.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
6.2 North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
6.3 North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country
6.3.1 North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2029)
6.3.2 United States Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
6.3.3 Canada Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
6.3.4 Mexico Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
7.2 Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
7.3 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country
7.3.1 Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2029)
7.3.2 Germany Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7.3.3 France Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7.3.5 Russia Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7.3.6 Italy Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region
8.3.1 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2018-2029)
8.3.2 China Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.3 Japan Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.4 South Korea Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.5 India Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.7 Australia Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
9.2 South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
9.3 South America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country
9.3.1 South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2029)
9.3.2 Brazil Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
9.3.3 Argentina Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country
10.3.1 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2029)
10.3.2 Turkey Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
10.3.4 UAE Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Long-Acting Injectable (LAI) Antipsychotic Market Drivers
11.2 Long-Acting Injectable (LAI) Antipsychotic Market Restraints
11.3 Long-Acting Injectable (LAI) Antipsychotic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Long-Acting Injectable (LAI) Antipsychotic Industry Chain
12.2 Long-Acting Injectable (LAI) Antipsychotic Upstream Analysis
12.3 Long-Acting Injectable (LAI) Antipsychotic Midstream Analysis
12.4 Long-Acting Injectable (LAI) Antipsychotic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope of Long-Acting Injectable (LAI) Antipsychotic
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Long-Acting Injectable (LAI) Antipsychotic by Type
1.3.1 Overview: Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Type: 2018 Versus 2022 Versus 2029
1.3.2 Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type in 2022
1.3.3 Aripiprazole
1.3.4 Fluphenazine
1.3.5 Haloperidol
1.3.6 Others
1.4 Global Long-Acting Injectable (LAI) Antipsychotic Market by Application
1.4.1 Overview: Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Application: 2018 Versus 2022 Versus 2029
1.4.2 Hospital
1.4.3 Retail Pharmacy
1.4.4 Others
1.5 Global Long-Acting Injectable (LAI) Antipsychotic Market Size & Forecast
1.6 Global Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast by Region
1.6.1 Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region: 2018 VS 2022 VS 2029
1.6.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Size by Region, (2018-2029)
1.6.3 North America Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
1.6.4 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
1.6.5 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
1.6.6 South America Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
1.6.7 Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Market Size and Prospect (2018-2029)
2 COMPANY PROFILES
2.1 Alkermes
2.1.1 Alkermes Details
2.1.2 Alkermes Major Business
2.1.3 Alkermes Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.1.4 Alkermes Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Alkermes Recent Developments and Future Plans
2.2 Eli Lilly and Company
2.2.1 Eli Lilly and Company Details
2.2.2 Eli Lilly and Company Major Business
2.2.3 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.2.4 Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Eli Lilly and Company Recent Developments and Future Plans
2.3 Janssen Global Services, LLC
2.3.1 Janssen Global Services, LLC Details
2.3.2 Janssen Global Services, LLC Major Business
2.3.3 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.3.4 Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Janssen Global Services, LLC Recent Developments and Future Plans
2.4 Abilify Maintena
2.4.1 Abilify Maintena Details
2.4.2 Abilify Maintena Major Business
2.4.3 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.4.4 Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Abilify Maintena Recent Developments and Future Plans
2.5 Haldol
2.5.1 Haldol Details
2.5.2 Haldol Major Business
2.5.3 Haldol Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.5.4 Haldol Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 Haldol Recent Developments and Future Plans
2.6 Otsuka Pharmaceutical
2.6.1 Otsuka Pharmaceutical Details
2.6.2 Otsuka Pharmaceutical Major Business
2.6.3 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.6.4 Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 Otsuka Pharmaceutical Recent Developments and Future Plans
2.7 Aristada
2.7.1 Aristada Details
2.7.2 Aristada Major Business
2.7.3 Aristada Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.7.4 Aristada Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Aristada Recent Developments and Future Plans
2.8 Prolixin
2.8.1 Prolixin Details
2.8.2 Prolixin Major Business
2.8.3 Prolixin Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
2.8.4 Prolixin Long-Acting Injectable (LAI) Antipsychotic Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Prolixin Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Long-Acting Injectable (LAI) Antipsychotic Revenue and Share by Players (2018-2023)
3.2 Market Share Analysis (2022)
3.2.1 Market Share of Long-Acting Injectable (LAI) Antipsychotic by Company Revenue
3.2.2 Top 3 Long-Acting Injectable (LAI) Antipsychotic Players Market Share in 2022
3.2.3 Top 6 Long-Acting Injectable (LAI) Antipsychotic Players Market Share in 2022
3.3 Long-Acting Injectable (LAI) Antipsychotic Market: Overall Company Footprint Analysis
3.3.1 Long-Acting Injectable (LAI) Antipsychotic Market: Region Footprint
3.3.2 Long-Acting Injectable (LAI) Antipsychotic Market: Company Product Type Footprint
3.3.3 Long-Acting Injectable (LAI) Antipsychotic Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value and Market Share by Type (2018-2023)
4.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Forecast by Type (2024-2029)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2023)
5.2 Global Long-Acting Injectable (LAI) Antipsychotic Market Forecast by Application (2024-2029)
6 NORTH AMERICA
6.1 North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
6.2 North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
6.3 North America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country
6.3.1 North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2029)
6.3.2 United States Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
6.3.3 Canada Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
6.3.4 Mexico Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7 EUROPE
7.1 Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
7.2 Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
7.3 Europe Long-Acting Injectable (LAI) Antipsychotic Market Size by Country
7.3.1 Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2029)
7.3.2 Germany Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7.3.3 France Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7.3.4 United Kingdom Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7.3.5 Russia Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
7.3.6 Italy Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8 ASIA-PACIFIC
8.1 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
8.2 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
8.3 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Market Size by Region
8.3.1 Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2018-2029)
8.3.2 China Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.3 Japan Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.4 South Korea Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.5 India Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.6 Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
8.3.7 Australia Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
9 SOUTH AMERICA
9.1 South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
9.2 South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
9.3 South America Long-Acting Injectable (LAI) Antipsychotic Market Size by Country
9.3.1 South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2029)
9.3.2 Brazil Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
9.3.3 Argentina Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2029)
10.2 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2029)
10.3 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Market Size by Country
10.3.1 Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2029)
10.3.2 Turkey Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
10.3.3 Saudi Arabia Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
10.3.4 UAE Long-Acting Injectable (LAI) Antipsychotic Market Size and Forecast (2018-2029)
11 MARKET DYNAMICS
11.1 Long-Acting Injectable (LAI) Antipsychotic Market Drivers
11.2 Long-Acting Injectable (LAI) Antipsychotic Market Restraints
11.3 Long-Acting Injectable (LAI) Antipsychotic Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
11.5 Influence of COVID-19 and Russia-Ukraine War
11.5.1 Influence of COVID-19
11.5.2 Influence of Russia-Ukraine War
12 INDUSTRY CHAIN ANALYSIS
12.1 Long-Acting Injectable (LAI) Antipsychotic Industry Chain
12.2 Long-Acting Injectable (LAI) Antipsychotic Upstream Analysis
12.3 Long-Acting Injectable (LAI) Antipsychotic Midstream Analysis
12.4 Long-Acting Injectable (LAI) Antipsychotic Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Alkermes Company Information, Head Office, and Major Competitors
Table 6. Alkermes Major Business
Table 7. Alkermes Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 8. Alkermes Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Alkermes Recent Developments and Future Plans
Table 10. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 11. Eli Lilly and Company Major Business
Table 12. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 13. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Eli Lilly and Company Recent Developments and Future Plans
Table 15. Janssen Global Services, LLC Company Information, Head Office, and Major Competitors
Table 16. Janssen Global Services, LLC Major Business
Table 17. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 18. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Janssen Global Services, LLC Recent Developments and Future Plans
Table 20. Abilify Maintena Company Information, Head Office, and Major Competitors
Table 21. Abilify Maintena Major Business
Table 22. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 23. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Abilify Maintena Recent Developments and Future Plans
Table 25. Haldol Company Information, Head Office, and Major Competitors
Table 26. Haldol Major Business
Table 27. Haldol Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 28. Haldol Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Haldol Recent Developments and Future Plans
Table 30. Otsuka Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Otsuka Pharmaceutical Major Business
Table 32. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 33. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Otsuka Pharmaceutical Recent Developments and Future Plans
Table 35. Aristada Company Information, Head Office, and Major Competitors
Table 36. Aristada Major Business
Table 37. Aristada Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 38. Aristada Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Aristada Recent Developments and Future Plans
Table 40. Prolixin Company Information, Head Office, and Major Competitors
Table 41. Prolixin Major Business
Table 42. Prolixin Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 43. Prolixin Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Prolixin Recent Developments and Future Plans
Table 45. Global Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million) by Players (2018-2023)
Table 46. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Share by Players (2018-2023)
Table 47. Breakdown of Long-Acting Injectable (LAI) Antipsychotic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Long-Acting Injectable (LAI) Antipsychotic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key Long-Acting Injectable (LAI) Antipsychotic Players
Table 50. Long-Acting Injectable (LAI) Antipsychotic Market: Company Product Type Footprint
Table 51. Long-Acting Injectable (LAI) Antipsychotic Market: Company Product Application Footprint
Table 52. Long-Acting Injectable (LAI) Antipsychotic New Market Entrants and Barriers to Market Entry
Table 53. Long-Acting Injectable (LAI) Antipsychotic Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Share by Type (2018-2023)
Table 56. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Forecast by Type (2024-2029)
Table 57. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023)
Table 58. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Forecast by Application (2024-2029)
Table 59. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2024-2029) & (USD Million)
Table 89. Long-Acting Injectable (LAI) Antipsychotic Raw Material
Table 90. Key Suppliers of Long-Acting Injectable (LAI) Antipsychotic Raw Materials
Table 1. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2018-2023) & (USD Million)
Table 4. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2024-2029) & (USD Million)
Table 5. Alkermes Company Information, Head Office, and Major Competitors
Table 6. Alkermes Major Business
Table 7. Alkermes Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 8. Alkermes Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 9. Alkermes Recent Developments and Future Plans
Table 10. Eli Lilly and Company Company Information, Head Office, and Major Competitors
Table 11. Eli Lilly and Company Major Business
Table 12. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 13. Eli Lilly and Company Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 14. Eli Lilly and Company Recent Developments and Future Plans
Table 15. Janssen Global Services, LLC Company Information, Head Office, and Major Competitors
Table 16. Janssen Global Services, LLC Major Business
Table 17. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 18. Janssen Global Services, LLC Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 19. Janssen Global Services, LLC Recent Developments and Future Plans
Table 20. Abilify Maintena Company Information, Head Office, and Major Competitors
Table 21. Abilify Maintena Major Business
Table 22. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 23. Abilify Maintena Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 24. Abilify Maintena Recent Developments and Future Plans
Table 25. Haldol Company Information, Head Office, and Major Competitors
Table 26. Haldol Major Business
Table 27. Haldol Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 28. Haldol Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 29. Haldol Recent Developments and Future Plans
Table 30. Otsuka Pharmaceutical Company Information, Head Office, and Major Competitors
Table 31. Otsuka Pharmaceutical Major Business
Table 32. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 33. Otsuka Pharmaceutical Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 34. Otsuka Pharmaceutical Recent Developments and Future Plans
Table 35. Aristada Company Information, Head Office, and Major Competitors
Table 36. Aristada Major Business
Table 37. Aristada Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 38. Aristada Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 39. Aristada Recent Developments and Future Plans
Table 40. Prolixin Company Information, Head Office, and Major Competitors
Table 41. Prolixin Major Business
Table 42. Prolixin Long-Acting Injectable (LAI) Antipsychotic Product and Solutions
Table 43. Prolixin Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 44. Prolixin Recent Developments and Future Plans
Table 45. Global Long-Acting Injectable (LAI) Antipsychotic Revenue (USD Million) by Players (2018-2023)
Table 46. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Share by Players (2018-2023)
Table 47. Breakdown of Long-Acting Injectable (LAI) Antipsychotic by Company Type (Tier 1, Tier 2, and Tier 3)
Table 48. Market Position of Players in Long-Acting Injectable (LAI) Antipsychotic, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2022
Table 49. Head Office of Key Long-Acting Injectable (LAI) Antipsychotic Players
Table 50. Long-Acting Injectable (LAI) Antipsychotic Market: Company Product Type Footprint
Table 51. Long-Acting Injectable (LAI) Antipsychotic Market: Company Product Application Footprint
Table 52. Long-Acting Injectable (LAI) Antipsychotic New Market Entrants and Barriers to Market Entry
Table 53. Long-Acting Injectable (LAI) Antipsychotic Mergers, Acquisition, Agreements, and Collaborations
Table 54. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value (USD Million) by Type (2018-2023)
Table 55. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Share by Type (2018-2023)
Table 56. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Forecast by Type (2024-2029)
Table 57. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023)
Table 58. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Forecast by Application (2024-2029)
Table 59. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 60. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 61. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 62. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 63. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2023) & (USD Million)
Table 64. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2024-2029) & (USD Million)
Table 65. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 66. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 67. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 68. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 69. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2023) & (USD Million)
Table 70. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2024-2029) & (USD Million)
Table 71. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 72. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 73. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 74. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 75. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2018-2023) & (USD Million)
Table 76. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Region (2024-2029) & (USD Million)
Table 77. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 78. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 79. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 80. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 81. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2023) & (USD Million)
Table 82. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2024-2029) & (USD Million)
Table 83. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2018-2023) & (USD Million)
Table 84. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type (2024-2029) & (USD Million)
Table 85. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2018-2023) & (USD Million)
Table 86. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Application (2024-2029) & (USD Million)
Table 87. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2018-2023) & (USD Million)
Table 88. Middle East & Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Country (2024-2029) & (USD Million)
Table 89. Long-Acting Injectable (LAI) Antipsychotic Raw Material
Table 90. Key Suppliers of Long-Acting Injectable (LAI) Antipsychotic Raw Materials
LIST OF FIGURES
Figure 1. Long-Acting Injectable (LAI) Antipsychotic Picture
Figure 2. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type in 2022
Figure 4. Aripiprazole
Figure 5. Fluphenazine
Figure 6. Haloperidol
Figure 7. Others
Figure 8. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Others Picture
Figure 13. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Long-Acting Injectable (LAI) Antipsychotic Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Region in 2022
Figure 18. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Share by Players in 2022
Figure 24. Long-Acting Injectable (LAI) Antipsychotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Long-Acting Injectable (LAI) Antipsychotic Market Share in 2022
Figure 26. Global Top 6 Players Long-Acting Injectable (LAI) Antipsychotic Market Share in 2022
Figure 27. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Share by Type (2018-2023)
Figure 28. Global Long-Acting Injectable (LAI) Antipsychotic Market Share Forecast by Type (2024-2029)
Figure 29. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Share by Application (2018-2023)
Figure 30. Global Long-Acting Injectable (LAI) Antipsychotic Market Share Forecast by Application (2024-2029)
Figure 31. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 41. France Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Region (2018-2029)
Figure 48. China Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 51. India Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 65. Long-Acting Injectable (LAI) Antipsychotic Market Drivers
Figure 66. Long-Acting Injectable (LAI) Antipsychotic Market Restraints
Figure 67. Long-Acting Injectable (LAI) Antipsychotic Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Long-Acting Injectable (LAI) Antipsychotic in 2022
Figure 70. Manufacturing Process Analysis of Long-Acting Injectable (LAI) Antipsychotic
Figure 71. Long-Acting Injectable (LAI) Antipsychotic Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
Figure 1. Long-Acting Injectable (LAI) Antipsychotic Picture
Figure 2. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type in 2022
Figure 4. Aripiprazole
Figure 5. Fluphenazine
Figure 6. Haloperidol
Figure 7. Others
Figure 8. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 9. Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application in 2022
Figure 10. Hospital Picture
Figure 11. Retail Pharmacy Picture
Figure 12. Others Picture
Figure 13. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 14. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 15. Global Market Long-Acting Injectable (LAI) Antipsychotic Consumption Value (USD Million) Comparison by Region (2018 & 2022 & 2029)
Figure 16. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Region (2018-2029)
Figure 17. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Region in 2022
Figure 18. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 19. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 20. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 21. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 22. Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 23. Global Long-Acting Injectable (LAI) Antipsychotic Revenue Share by Players in 2022
Figure 24. Long-Acting Injectable (LAI) Antipsychotic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2022
Figure 25. Global Top 3 Players Long-Acting Injectable (LAI) Antipsychotic Market Share in 2022
Figure 26. Global Top 6 Players Long-Acting Injectable (LAI) Antipsychotic Market Share in 2022
Figure 27. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Share by Type (2018-2023)
Figure 28. Global Long-Acting Injectable (LAI) Antipsychotic Market Share Forecast by Type (2024-2029)
Figure 29. Global Long-Acting Injectable (LAI) Antipsychotic Consumption Value Share by Application (2018-2023)
Figure 30. Global Long-Acting Injectable (LAI) Antipsychotic Market Share Forecast by Application (2024-2029)
Figure 31. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 32. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 33. North America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Country (2018-2029)
Figure 34. United States Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 35. Canada Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 36. Mexico Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 37. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 38. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 39. Europe Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Country (2018-2029)
Figure 40. Germany Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 41. France Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 42. United Kingdom Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 43. Russia Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 44. Italy Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 45. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 46. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 47. Asia-Pacific Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Region (2018-2029)
Figure 48. China Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 49. Japan Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 50. South Korea Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 51. India Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 52. Southeast Asia Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 53. Australia Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 54. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 55. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 56. South America Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Country (2018-2029)
Figure 57. Brazil Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 58. Argentina Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 59. Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Type (2018-2029)
Figure 60. Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Application (2018-2029)
Figure 61. Middle East and Africa Long-Acting Injectable (LAI) Antipsychotic Consumption Value Market Share by Country (2018-2029)
Figure 62. Turkey Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 63. Saudi Arabia Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 64. UAE Long-Acting Injectable (LAI) Antipsychotic Consumption Value (2018-2029) & (USD Million)
Figure 65. Long-Acting Injectable (LAI) Antipsychotic Market Drivers
Figure 66. Long-Acting Injectable (LAI) Antipsychotic Market Restraints
Figure 67. Long-Acting Injectable (LAI) Antipsychotic Market Trends
Figure 68. Porters Five Forces Analysis
Figure 69. Manufacturing Cost Structure Analysis of Long-Acting Injectable (LAI) Antipsychotic in 2022
Figure 70. Manufacturing Process Analysis of Long-Acting Injectable (LAI) Antipsychotic
Figure 71. Long-Acting Injectable (LAI) Antipsychotic Industrial Chain
Figure 72. Methodology
Figure 73. Research Process and Data Source
